Intuitive Surgical Q1 2026: Can Robotic Surgery Reclaim Its Premium?
Intuitive Surgical reports Q1 2026 earnings April 21 with its stock down 20% YTD. Here’s what analysts are watching — from da Vinci 5 adoption to the China challenge.
Intuitive Surgical reports Q1 2026 earnings April 21 with its stock down 20% YTD. Here’s what analysts are watching — from da Vinci 5 adoption to the China challenge.
UnitedHealth reports Q1 2026 earnings April 22. Medical loss ratios, Medicaid risk, Optum growth — and what it means for healthcare stocks.
The IMF says runaway U.S. debt is eliminating the traditional safety premium on Treasury bonds — and the implications stretch far beyond fixed income.
QXO, led by serial dealmaker Brad Jacobs, agreed to acquire building products leader TopBuild for $17 billion—one of 2026’s largest M&A transactions.
Google is in talks with Marvell to build next-gen AI inference chips. Here’s what the custom silicon arms race means for MRVL, NVDA, and the broader semiconductor sector.
U.S. utilities are planning $1.4 trillion in capex to power AI data centers — and financing it means a $770B bond issuance wave that will reshape investment-grade credit markets.
Enterprise software is rebounding in 2026, but gains are selective. RingCentral and Oracle reveal what separates the winners from the laggards.
Sticky 3.3% inflation, oil price shocks, and a Fed frozen on rate cuts are reviving stagflation fears not seen since the 1970s. Here’s what capital markets are signaling.
Tesla reports Q1 2026 earnings on April 22. Here’s what analysts are watching after the delivery miss, the robotaxi rollout, and a P/E above 370.
20 of 21 major U.S. financials beat Q1 2026 earnings estimates. Morgan Stanley and Citi lead; Wells Fargo lags. Here’s what’s driving results.